Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.2 SEK | +0.10% | +81.83% | +63.81% |
31/05 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
31/05 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.81% | 106.08Cr | |
+15.54% | 7.85TCr | |
+13.27% | 900.15Cr | |
+58.17% | 496.1Cr | |
-14.94% | 483.61Cr | |
-.--% | 372.43Cr | |
-26.63% | 218.54Cr | |
+16.75% | 211.67Cr | |
-37.97% | 194.2Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Calliditas Therapeutics AB Elects Molly Henderson as Member of the Board of Directors